Studies heart transplants from donors who have hepatitis C
Looks at outcomes of heart transplants using donor hearts carrying hepatitis C in adults.
Key facts
- Who runs it
- Baylor Research Institute
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- The Hepatitis C Transplant Collaborative
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 16 Sept 2019
- Expected to end
- Dec 2030
- Type of study
- Observational
- Record updated
- 22 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who received a heart from a donor with proven hepatitis C (HCV NAT+). People having a second heart transplant can join.
- Age
- 18 Years and older
- Sex
- All sexes can join.
- Earlier treatment
- Received a donor heart that tested HCV NAT+. Repeat (re-transplant) patients can join.
- Biomarker or test result
- The donor heart must be proven HCV NAT+.
Main reasons for not taking part
- Transplant of more than one organ (multi-organ transplantation)
This trial only enrols participants who have had an organ transplant. The registry sentence this rests on: Recipient of a proven HCV NAT+ donor heart.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Recipient of a proven HCV NAT+ donor heart
- Re-transplant patients will be included
Who cannot take part
- Multi-organ transplantation
Where in United States
- Baylor Scott & White health research instituteDallas, United StatesContact: Joost Felius, PhDTaking people
About the trial
What the trial wants to find out
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Nationwide Hepatitis C NAT+ Cardiac Transplant Experience
- Plain-language title
- Studies heart transplants from donors who have hepatitis CGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 22 January 2026